Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q2

Bladder Cancer

SAGE Publications Ltd

United KingdomUrology (Q2); Oncology (Q3)ISSN-matched source record
Submission information ↗
Q2Ranking
—Impact Factor (year unverified)
33H-index (SCImago 2025)
0.595SJR (2025)
2015-2024Coverage

About Bladder Cancer

Bladder Cancer is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.595 and H-index of 33.

Coverage: 2015-2024. Research categories: Urology (Q2); Oncology (Q3).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2025-06-10. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 2800 USD
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS
Reported submission-to-publication time20 weeks on average; not a guarantee
Openly licensed content since2023 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2352-3727, 2352-3735
ISSN-L2352-3727
Source typeJournal
Publisher / hosting organisationIOS Press
Publisher country codeNL
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex684
Citations recorded in OpenAlex5,651
OpenAlex H-index37
Years represented in OpenAlex1999–2026 (not the founding or closing dates)

Topics in published research

Bladder and Urothelial Cancer Treatments; Urinary and Genital Oncology Studies; Urological Disorders and Treatments; Urinary Bladder and Prostate Research; Urinary Tract Infections Management; Cancer Immunotherapy and Biomarkers.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit